Petrosal_sinus_sampling_with_and_without_corticotropin-releasing_hormone_for_the_differential_diagnosis_of_Cushing's_syndrome__BACKGROUND._Measurement_of_adrenocorticotropin_levels_in_plasma_from_the_inferior_petrosal_sinuses_of_patients_with_Cushing's_syndrome_can_distinguish_adrenocorticotropin-secreting_pituitary_tumors_(Cushing's_disease)_from_other_causes_of_the_syndrome,_principally_ectopic_adrenocorticotropin_secretion_from_an_occult_tumor._However,_it_is_unknown_whether_such_measurement_consistently_identifies_patients_with_Cushing's_disease_and_whether_testing_with_corticotropin-releasing_hormone_(CRH)_enhances_the_value_of_the_procedure._METHODS._We_prospectively_studied_281_patients_with_Cushing's_syndrome_to_evaluate_the_diagnostic_efficacy_of_the_procedure._Bilateral_sampling_was_successfully_accomplished_in_278_patients,_with_no_major_morbidity;_262_of_these_patients_underwent_sampling_before_and_after_administration_of_ovine_CRH._The_adrenocorticotropin_levels_in_the_samples_were_used_to_calculate_the_ratio_of_the_concentration_in_plasma_from_the_inferior_petrosal_sinuses_to_the_concentration_in_peripheral-blood_plasma_(the_IPS:P_ratio)._RESULTS._The_diagnosis_of_246_patients_was_confirmed_surgically_as_Cushing's_disease_in_215,_as_ectopic_adrenocorticotropin_syndrome_in_20,_and_as_primary_adrenal_disease_in_11._An_IPS:P_ratio_greater_than_or_equal_to_2.0_in_basal_samples_identified_205_of_the_215_patients_with_Cushing's_disease_(sensitivity,_95_percent),_with_no_false_positive_results_(specificity,_100_percent)._A_peak_IPS:P_ratio_greater_than_or_equal_to_3.0_after_CRH_administration_identified_all_203_of_the_patients_with_Cushing's_disease_who_received_CRH_(sensitivity,_100_percent),_with_no_false_positive_results_(specificity,_100_percent)._The_sensitivity_was_much_lower_when_the_adrenocorticotropin_concentrations_in_the_samples_from_one_sinus_were_considered_alone._In_patients_with_Cushing's_disease_a_difference_of_greater_than_or_equal_to_1.4-fold_between_the_concentrations_in_the_two_sinuses_(the_adrenocorticotropin_gradient)_predicted_the_location_of_the_microadenoma_in_68_percent_of_104_patients_during_basal_sampling_and_in_71_percent_of_105_patients_after_CRH_administration._CONCLUSIONS._Simultaneous_bilateral_sampling_of_plasma_from_the_inferior_petrosal_sinuses,_with_the_adjunctive_use_of_CRH,_distinguishes_patients_with_Cushing's_disease_from_those_with_ectopic_adrenocorticotropin_secretion_with_high_diagnostic_accuracy.